Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome

Lookup NU author(s): Dr Sally Johnson, Dr Michal Malina

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© 2018 International Society of Nephrology Atypical hemolytic uremic syndrome (aHUS) is a rare, genetic, life-threatening disease. The Global aHUS Registry collects real-world data on the natural history of the disease. Here we characterize end-stage renal disease (ESRD)-free survival, the rate of thrombotic microangiopathy, organ involvement and the genetic background of 851 patients in the registry, prior to eculizumab treatment. A sex-specific difference was apparent according to age at initial disease onset as the ratio of males to females was 1.3:1 for childhood presentation and 1:2 for adult presentation. Complement Factor I and Membrane Cofactor Protein mutations were more common in patients with initial presentation as adults and children, respectively. Initial presentation in childhood significantly predicted ESRD risk (adjusted hazard ratio 0.55 [95% confidence interval 0.41–0.73], whereas sex, race, family history of aHUS, and time from initial presentation to diagnosis, did not. Patients with a Complement Factor H mutation had reduced ESRD-free survival, whereas Membrane Cofactor Protein mutation was associated with longer ESRD-free survival. Additionally extrarenal organ manifestations occur in 19%–38% of patients within six months of initial disease presentation (dependent on organ). Thus, our real-world results provide novel insights regarding phenotypic variables and genotypes on the clinical manifestation and progression of aHUS.


Publication metadata

Author(s): Schaefer F, Ardissino G, Ariceta G, Fakhouri F, Scully M, Isbel N, Lommele A, Kupelian V, Gasteyger C, Greenbaum LA, Johnson S, Ogawa M, Licht C, Vande Walle J, Fremeaux-Bacchi V, Blasco M, Cresseri D, Generolova G, Webb N, Hirt-Minkowski P, Lvovna Kozlovskaya N, Landau D, Lapeyraque A-L, Loirat C, Mache C, Malina M, Martola L, Massart A, Rondeau E, Siedlecki A, Sartz L

Publication type: Article

Publication status: Published

Journal: Kidney International

Year: 2018

Volume: 94

Issue: 2

Pages: 408-418

Print publication date: 01/08/2018

Online publication date: 19/06/2018

Acceptance date: 15/02/2018

ISSN (print): 0085-2538

ISSN (electronic): 1523-1755

Publisher: Elsevier Inc.

URL: https://doi.org/10.1016/j.kint.2018.02.029

DOI: 10.1016/j.kint.2018.02.029


Altmetrics

Altmetrics provided by Altmetric


Share